These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22814809)

  • 21. The influence of drop size of cyclopentolate, phenylephrine and tropicamide on pupil dilatation and systemic side effects in infants.
    Elibol O; Alçelik T; Yüksel N; Caglar Y
    Acta Ophthalmol Scand; 1997 Apr; 75(2):178-80. PubMed ID: 9197568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclopentolate eye drops-induced anaphylaxis in an infant.
    Terece SP; Ertoy-Karagöl Hİ; Köken G; Atalay HT; Türkcan BT; Vural Ö; Bakırtaş A
    Turk J Pediatr; 2022; 64(5):915-918. PubMed ID: 36305442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Neurological complications in topical administration of mydriatics].
    Olivè Plana JM; Alonso-Villaverde C; González J; Borrás S
    Med Clin (Barc); 1991 Jun; 97(2):76-7. PubMed ID: 1895790
    [No Abstract]   [Full Text] [Related]  

  • 24. Epileptic seizures induced by cycloplegic eye drops.
    Wygnanski-Jaffe T; Nucci P; Goldchmit M; Mezer E
    Cutan Ocul Toxicol; 2014 Jun; 33(2):103-8. PubMed ID: 23815170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Toxic effects of cyclopentolate. Case of severe dysarthria with transitory loss of phonation].
    Missiroli A
    Boll Ocul; 1969 Jun; 48(6):433-8. PubMed ID: 5396327
    [No Abstract]   [Full Text] [Related]  

  • 26. Cyclopentolate hydrochloride eye drops addiction: a case report.
    Darcin AE; Dilbaz N; Yilmaz S; Cetin MK
    J Addict Med; 2011 Mar; 5(1):84-5. PubMed ID: 21769052
    [No Abstract]   [Full Text] [Related]  

  • 27. Fatal necrotising enterocolitis due to mydriatic eye drops.
    Ozgun U; Demet T; Ozge KA; Zafer D; Murat S; Mehmet Y; Nilgun K
    J Coll Physicians Surg Pak; 2014 May; 24 Suppl 2():S147-9. PubMed ID: 24906272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular effects of mydriatics in low-birth-weight infants.
    Isenberg S; Everett S
    J Pediatr; 1984 Jul; 105(1):111-2. PubMed ID: 6737125
    [No Abstract]   [Full Text] [Related]  

  • 29. Systemic toxicity with cyclopentolate eye drop.
    Tripathi SK; Mondal TK
    J Indian Med Assoc; 1990 Sep; 88(9):266. PubMed ID: 2286766
    [No Abstract]   [Full Text] [Related]  

  • 30. Seizures associated with 1% cyclopentolate eyedrops.
    Fitzgerald DA; Hanson RM; West C; Martin F; Brown J; Kilham HA
    J Paediatr Child Health; 1990 Apr; 26(2):106-7. PubMed ID: 2113819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic Absorption of Cyclopentolate and Adverse Events After Retinopathy of Prematurity Exams.
    Mitchell A; Hall RW; Erickson SW; Yates C; Lowery S; Hendrickson H
    Curr Eye Res; 2016 Dec; 41(12):1601-1607. PubMed ID: 27159349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transient paralytic ileus following the use of cyclopentolate-phenylephrine eye drops during screening for retinopathy of prematurity.
    Lim DL; Batilando M; Rajadurai VS
    J Paediatr Child Health; 2003; 39(4):318-20. PubMed ID: 12755944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adverse reactions to topical ocular autonomic agents.
    Norden LC
    J Am Optom Assoc; 1978 Jan; 49(1):75-80. PubMed ID: 146723
    [No Abstract]   [Full Text] [Related]  

  • 34. [Phacoemulsification without mydriasis before surgery: benefits to the patient].
    Benatar-Haserfaty J; Alvarez de Rementería-Fernández L; Muriel García A
    Arch Soc Esp Oftalmol; 2004 Feb; 79(2):53-8. PubMed ID: 14988783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reliability of diagnostic tests for contact allergy to mydriatic eyedrops.
    Villarreal O
    Contact Dermatitis; 1998 Mar; 38(3):150-4. PubMed ID: 9536407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic effects of eye drops.
    Davidson SI
    Trans Ophthalmol Soc U K (1962); 1974 Jul; 94(2):487-95. PubMed ID: 4143267
    [No Abstract]   [Full Text] [Related]  

  • 37. Optimal dosage of cyclopentolate 1% for complete cycloplegia: a randomized clinical trial.
    Bagheri A; Givrad S; Yazdani S; Reza Mohebbi M
    Eur J Ophthalmol; 2007; 17(3):294-300. PubMed ID: 17534806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contact urticaria due to cyclopentolate hydrochloride.
    Muñoz-Bellido FJ; Beltrán A; Bellido J
    Allergy; 2000 Feb; 55(2):198-9. PubMed ID: 10726741
    [No Abstract]   [Full Text] [Related]  

  • 39. [Acute psychosis after cyclopentolate-HCL (Zyklolat) (author's transl)].
    Huismans H
    Klin Monbl Augenheilkd; 1979 Jul; 175(1):100-2. PubMed ID: 491456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CLINICAL EVALUATION OF A NEW MYDRIATIC-MYDRILATE.
    Cowan EC; Archer D
    Br J Ophthalmol; 1962 Dec; 46(12):730-6. PubMed ID: 18170843
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.